Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limitedverified

KNTPF

Price:

$0.216

Market Cap:

$789.81M

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hep...[Read more]

Industry

Biotechnology

IPO Date

2020-12-11

Stock Exchange

OTC

Ticker

KNTPF

The PE Ratio as of December 2025 (TTM) for Kintor Pharmaceutical Limited (KNTPF) is -4.32

According to Kintor Pharmaceutical Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.32. This represents a change of -90.81% compared to the average of -47.02 of the last 4 quarters.

Kintor Pharmaceutical Limited (KNTPF) Historical PE Ratio (quarterly & annually)

How has KNTPF PE Ratio performed in the past?

The mean historical PE Ratio of Kintor Pharmaceutical Limited over the last ten years is -3842.26. The current -4.32 PE Ratio has changed -88.76% with respect to the historical average. Over the past ten years (40 quarters), KNTPF's PE Ratio was at its highest in in the December 2014 quarter at 0. The PE Ratio was at its lowest in in the December 2016 quarter at -72140.44.

Quarterly (TTM)
Annual

Average

-3842.26

Median

-12.56

Minimum

-37980.65

Maximum

-0.60

Kintor Pharmaceutical Limited (KNTPF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kintor Pharmaceutical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.63%

Maximum Annual PE Ratio = -0.60

Minimum Annual Increase = -99.95%

Minimum Annual PE Ratio = -37980.65

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.53320.41%
2023-0.60-82.49%
2022-3.43-19.05%
2021-4.24-20.84%
2020-5.36-72.90%
2019-19.77-99.95%
2018-37980.6550.63%
2017-74.8712.45%
2016-66.58-74.84%
2015-264.61-12.19%

Kintor Pharmaceutical Limited (KNTPF) Average PE Ratio

How has KNTPF PE Ratio performed in the past?

The current PE Ratio of Kintor Pharmaceutical Limited (KNTPF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.19

5-year avg

-3.23

10-year avg

-3842.26

Kintor Pharmaceutical Limited (KNTPF) PE Ratio vs. Peers

How is KNTPF’s PE Ratio compared to its peers?

Kintor Pharmaceutical Limited’s PE Ratio is greater than Paradigm Biopharmaceuticals Limited (-7.47), less than Poolbeg Pharma PLC (-3.30), greater than Nuo Therapeutics, Inc. (-44.21), greater than Hofseth BioCare ASA (-4.78), less than Imugene Limited (-1.02), less than Satellos Bioscience Inc. (-1.76), greater than Scancell Holdings plc (-7.91), greater than Shield Therapeutics plc (-7.14), less than VitaSpring Biomedical Co. Ltd. (162.96), less than Innate Pharma S.A. (-3.11),

Build a custom stock screener for Kintor Pharmaceutical Limited (KNTPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintor Pharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kintor Pharmaceutical Limited (KNTPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kintor Pharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kintor Pharmaceutical Limited's PE Ratio?

How is the PE Ratio calculated for Kintor Pharmaceutical Limited (KNTPF)?

What is the highest PE Ratio for Kintor Pharmaceutical Limited (KNTPF)?

What is the 3-year average PE Ratio for Kintor Pharmaceutical Limited (KNTPF)?

What is the 5-year average PE Ratio for Kintor Pharmaceutical Limited (KNTPF)?

How does the current PE Ratio for Kintor Pharmaceutical Limited (KNTPF) compare to its historical average?